Pharmacological inhibition of CK1δ with LH846 reverses these effects—restoring SNAPIN localization, lysosomal acidification, and mitophagy—highlighting CK1δ as both an effector of Vpr toxicity and a promising therapeutic target in HAND. This evidence concerns the gene SNAPIN and HIV-associated neurocognitive disorder.